Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 52
- −3 vs. Q3 2021
- Portfolio value
- $122.3M
- −$1.06M (−0.9%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| XERSXeris Biopharma Holdings, Inc. | COM | 6,310,546 | $18.5M | 15.1% | +6,310,546 | New | History |
| CRDFCardiff Oncology, Inc. | COM | 2,522,083 | $15.2M | 12.4% | 00.0% | Unchanged | History |
| SCYXScynexis Inc | COM NEW | 1,748,786 | $10.7M | 8.7% | +184,386+11.8% | Added | History |
| SVRASavara Inc | COM | 6,916,551 | $8.58M | 7.0% | +20,000+0.3% | Added | History |
| MTEMMolecular Templates, Inc. | COM | 2,137,991 | $8.38M | 6.9% | 00.0% | Unchanged | History |
| GLDSPDR Gold Trust | ETF | 40,820 | $6.98M | 5.7% | 00.0% | Unchanged | History |
| SRRASierra Oncology, Inc. | COM NEW | 262,969 | $5.72M | 4.7% | −179,785−40.6% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 1,193,473 | $5.71M | 4.7% | +769,230+181.3% | Added | History |
| CTICCti Biopharma Corp | COM | 2,239,300 | $5.55M | 4.5% | +1,239,300+123.9% | Added | History |
| Pershing Square Tontine Hldg71531R109 | COM CL A | 227,000 | $4.48M | 3.7% | +227,000 | New | – |
| SPYSPDR S&P 500 ETF Trust | ETF | 6,980 | $3.31M | 2.7% | +3,500+100.6% | Added | History |
| Lux Health Tech Acquisition55068A100 | COM CL A | 200,000 | $1.96M | 1.6% | 00.0% | Unchanged | – |
| ADXNAddex Therapeutics Ltd. | SPONSORED ADS | 265,940 | $1.67M | 1.4% | 00.0% | Unchanged | History |
| iShares MSCI Eafe ETF464287465 | ETF | 19,000 | $1.50M | 1.2% | 00.0% | Unchanged | – |
| Ares Acquisition CorporationG33032114 | UNIT 99/99/9999 | 139,680 | $1.39M | 1.1% | 00.0% | Unchanged | – |
| INTUIntuit Inc. | Stock | 1,989 | $1.28M | 1.0% | +105+5.6% | Added | History |
| GOOGAlphabet Inc. | Stock | 399 | $1.16M | 0.9% | +27+7.3% | Added | History |
| MSFTMicrosoft Corp | Stock | 3,299 | $1.11M | 0.9% | +242+7.9% | Added | History |
| SPGIS&P Global Inc. | Stock | 2,251 | $1.06M | 0.9% | +179+8.6% | Added | History |
| MCOMoodys Corp | Stock | 2,600 | $1.01M | 0.8% | +220+9.2% | Added | History |
| METAMeta Platforms, Inc. | Stock | 2,840 | $955.0K | 0.8% | +275+10.7% | Added | History |
| AMTAmerican Tower Corp | REIT | 3,240 | $948.0K | 0.8% | +346+12.0% | Added | History |
| WHRWhirlpool Corp | Stock | 3,906 | $917.0K | 0.7% | +418+12.0% | Added | History |
| NFLXNetflix Inc | Stock | 1,513 | $912.0K | 0.7% | +156+11.5% | Added | History |
| MDLZMondelez International, Inc. | Stock | 13,582 | $901.0K | 0.7% | +1,544+12.8% | Added | History |
| TDGTransDigm Group INC | COM | 1,407 | $895.0K | 0.7% | +169+13.7% | Added | History |
| MAMastercard Inc | Stock | 2,469 | $887.0K | 0.7% | +285+13.0% | Added | History |
| VVisa Inc. | Stock | 3,981 | $863.0K | 0.7% | +468+13.3% | Added | History |
| CRMSalesforce, Inc. | Stock | 3,346 | $850.0K | 0.7% | +360+12.1% | Added | History |
| CHTRCharter Communications, Inc. | CL A | 1,230 | $802.0K | 0.7% | +169+15.9% | Added | History |
| DISWalt Disney Co | Stock | 5,082 | $787.0K | 0.6% | +685+15.6% | Added | History |
| CVNACarvana Co. | CL A | 3,316 | $769.0K | 0.6% | +430+14.9% | Added | History |
| FICOFair Isaac Corp | COM | 1,739 | $754.0K | 0.6% | +254+17.1% | Added | History |
| PYPLPayPal Holdings, Inc. | Stock | 3,633 | $685.0K | 0.6% | +575+18.8% | Added | History |
| FLACFrazier Lifesciences Acquisition Corp | CL A SHS | 64,000 | $624.0K | 0.5% | 00.0% | Unchanged | History |
| Bridgetown Holdings LtdG1355U113 | COM CL A | 62,688 | $616.0K | 0.5% | 00.0% | Unchanged | – |
| Science Strategic Acq Alpha808641203 | UNIT 01/20/2026 | 62,000 | $613.0K | 0.5% | 00.0% | Unchanged | – |
| EIGREiger BioPharmaceuticals, Inc. | COM | 116,884 | $607.0K | 0.5% | −23,738−16.9% | Reduced | History |
| HumanCo Acquisition Corp.44487N208 | UNIT 12/08/2023 | 57,724 | $585.0K | 0.5% | 00.0% | Unchanged | – |
| CDLXCardlytics, Inc. | COM | 8,740 | $578.0K | 0.5% | +1,939+28.5% | Added | History |
| ELEVElevation Acquisition Group Inc. | COM | 55,299 | $333.0K | 0.3% | +7,116+14.8% | Added | History |
| SVF Investment Corp.G8601L102 | CL A SHS | 27,900 | $280.0K | 0.2% | 00.0% | Unchanged | – |
| Primavera Capital Acquist CoG7255E109 | SHS CL A | 24,000 | $233.0K | 0.2% | 00.0% | Unchanged | – |
| ScION Tech Growth IG31067120 | UNIT 12/17/2025 | 22,410 | $223.0K | 0.2% | 00.0% | Unchanged | – |
| Pivotal Investment Corp III72582M205 | UNIT 01/28/2028 | 16,800 | $166.0K | 0.1% | 00.0% | Unchanged | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 16,009 | $158.0K | 0.1% | 00.0% | Unchanged | History |
| RMG Acquisition Corp IIIG76088114 | UNIT 02/08/2026 | 11,000 | $109.0K | 0.1% | 00.0% | Unchanged | – |
| Lux Health Tech Acquisition55068A118 | *W EXP 11/30/202 | 66,666 | $57.0K | <0.1% | 00.0% | Unchanged | – |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 39,773 | $36.0K | <0.1% | 00.0% | Unchanged | – |
| KALAKALA BIO, Inc. | COM | 13,155 | $16.0K | <0.1% | −1,714,596−99.2% | Reduced | History |
| Frazier Lifesciences Acqu CoG3710A113 | *W EXP 11/30/202 | 21,333 | $12.0K | <0.1% | 00.0% | Unchanged | – |
| Primavera Capital Acquist CoG7255E117 | *W EXP 01/19/202 | 12,000 | $8.00K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q3 2021 (5)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| SBBPStrongbridge Biopharma plc | SHS USD | 8,024,542 | $16.4M | 13.3% | History |
| GIGCAPITAL4 Inc37518G200 | UNIT 99/99/9999 | 45,000 | $459.0K | 0.4% | – |
| Switchback II CorpG8633T123 | UNIT 99/99/9999 | 39,000 | $398.0K | 0.3% | – |
| Boa Acquisition Corp05601A208 | UNIT 99/99/9999 | 34,070 | $337.0K | 0.3% | – |
| Cazoo Group LtdG2007L113 | *W EXP 08/26/202 | 62,500 | $94.0K | 0.1% | – |